Director/PDMR Shareholding
Source: RNS
16 May 2024
Golden Prospect Precious Metals Limited (the "Company")
Director/PDMR shareholding
The Company wishes to announce in accordance with DTR 3.1 and Article 19 of the UK Market Abuse Regulation the following dealing in the Company's ordinary shares of no par value by persons discharging managerial responsibility:
|
Details of the person discharging managerial responsibilities/person closely associated |
|||||
|
Name |
Monica Tepes
|
||||
|
|
|||||
|
Reason for the notification
|
|||||
|
Position/status |
Independent Director of the Board
|
||||
|
Initial Notification Amendment |
Initial Notification
|
||||
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
Name |
Golden Prospect Precious Metals Limited |
||||
|
LEI |
549300SD5YLRIUMG395
|
||||
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
Description of the financial instrument, type of instrument Identification code |
Ordinary shares
ISIN: GG00B1G9T992
|
||||
|
Nature of the transaction |
Purchase
|
||||
|
Price(s) and volume(s) |
|
||||
|
Aggregated information - Aggregated volume - Price |
25,000 £8,863.88 |
||||
|
Date of the transaction |
15 May 2024
|
||||
|
Place of the transaction |
LONDON STOCK EXCHANGE, (XLON) |
||||
|
Additional Information |
|
||||
This announcement is made in accordance with the requirements of the UK Market Abuse Regulation ("MAR") and the Company confirms that the PDMR's notification obligations under MAR have also been satisfied.
Enquiries:
Apex Administration (Guernsey) Limited
James Taylor +44 (0) 2035 303 600
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
